Skip to main content

Table 2 Recurrent Neurologic Event Rate

From: Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla® Flex II Occluder

Study

TIA

Ischemic Stroke

Follow-Up Period

RESPECT Trial (AmplatzerTM)9

6/499 (1.2 %)

9/499 (1.8 %)

2.6 years (mean)

PC Trial (AmplatzerTM)11

5/204 (2.5 %)

1/204 (0.5 %)

4.1 years (mean)

CLOSURE I Trial (STARFlex®)10

13/447 (3.1 %)a

12/447 (2.9)a

2 years

Fischer et al. (AmplatzerTM)27

2/113 (1.8 %)

1/113 (0.9 %)

17.7 months (mean)

Krizianic et al. (Figulla® N)23

0/34 (0 %)

1/34 (2.9 %)

6 months

Aytemir et al. (Figulla®)19

1/85 (1.2 %)

0/85 (0 %)

17.0 months (mean)

  1. aIntention-to-treat-population